Humana (DE:HUM)
NYSE:HUM
HUM Stock Chart & Stats
€174.00
€4.40(1.74%)
At close: 4:00 PM EST
€174.00
€4.40(1.74%)
Day’s Range― - ―
52-Week Range€142.00 - €282.00
Previous CloseN/A
Volume0.00
Average Volume (3M)6.00
Market Cap
€33.17B
Enterprise Value€45.71B
Total Cash (Recent Filing)€21.96B
Total Debt (Recent Filing)€13.99B
Price to Earnings (P/E)34.2
Beta0.33
Next Earnings
Jul 29, 2026EPS Estimate
5.92Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)9.38
Shares Outstanding120,061,500
10 Day Avg. Volume0
30 Day Avg. Volume6
Financial Highlights & Ratios
PEG Ratio-18.57
Price to Book (P/B)1.75
Price to Sales (P/S)0.24
P/FCF Ratio82.27
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€238.84Price Target Upside37.26% Upside
Rating ConsensusHold
Number of Analyst Covering19
EPS Forecast (FY)7.69
Revenue Forecast (FY)€139.73B
Bulls Say, Bears Say
Bulls Say
Medicare Advantage / Membership ScaleSustained Medicare Advantage and Medicaid membership growth increases predictable, risk‑adjusted capitation revenue and scale benefits. Over 2–6 months this underpins enrollment-driven revenue durability, bargaining leverage with providers, and an improving base for Stars-driven quality payments.
Vertical Integration: CenterWell Primary Care And PharmacyExpanding CenterWell and integrated pharmacy capabilities deepen Humana’s provider and care-delivery footprint, enabling tighter care coordination and cost control. This structural move supports value‑based care economics and member retention, improving long‑run margin and clinical outcomes potential.
Improved Liquidity And Capital FlexibilityRecent capital actions and entity-level mitigations (junior notes, reinsurance/legal changes) bolster committed liquidity and reduce near‑term recapitalization risk. This durable improvement in funding flexibility supports strategic investments and cushions execution of margin-recovery plans.
Bears Say
Compressed Profitability / Low Net MarginMaterial margin compression to sub‑1% leaves earnings highly sensitive to utilization and pricing variances. Persistently lower margins reduce ROE and internal reinvestment capacity, making long‑term targets harder to achieve without sustained structural cost or funding improvements.
Elevated Reserves / IBNR GrowthSharp, conservative reserve builds increase capital consumption and signal unpredictable claim development. Elevated IBNR creates earnings volatility and constrains cash generation over multiple quarters, complicating planning and making margin recovery more contingent on claim visibility.
Contingent Cash Obligations And Funding RiskMaterial potential put obligations create a structural liquidity overhang that can force asset sales, limit capital returns, or increase borrowing costs if exercised. Even if planned for, the optionality raises execution risk for strategic investments and margin programs over the medium term.
Humana News
HUM FAQ
What was Humana’s price range in the past 12 months?
Humana lowest stock price was €142.00 and its highest was €282.00 in the past 12 months.
What is Humana’s market cap?
Humana’s market cap is €33.17B.
When is Humana’s upcoming earnings report date?
Humana’s upcoming earnings report date is Jul 29, 2026 which is in 55 days.
How were Humana’s earnings last quarter?
Humana released its earnings results on Apr 29, 2026. The company reported €8.876 earnings per share for the quarter, beating the consensus estimate of €8.82 by €0.056.
Is Humana overvalued?
According to Wall Street analysts Humana’s price is currently Undervalued.
Does Humana pay dividends?
Humana does not currently pay dividends.
What is Humana’s EPS estimate?
Humana’s EPS estimate is 5.92.
How many shares outstanding does Humana have?
Humana has 120,061,500 shares outstanding.
What happened to Humana’s price movement after its last earnings report?
Humana reported an EPS of €8.876 in its last earnings report, beating expectations of €8.82. Following the earnings report the stock price went up 5.102%.
Which hedge fund is a major shareholder of Humana?
Currently, no hedge funds are holding shares in DE:HUM
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Humana Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
€238.84 (37.26% Upside)
€238.84 (37.26% Upside)
Blogger Sentiment
Bullish
DE:HUM Sentiment 70%
Sector Average ―
Sector Average ―
News Sentiment
Very Bullish
Bullish news 99%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
42.53%
12-Months-Change
Fundamentals
Return on Equity
6.19%
Trailing 12-Months
Asset Growth
8.54%
Trailing 12-Months
Company Description
Humana
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, and home solutions services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2021, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
HUM Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed constructive progress on strategic priorities — membership growth, CenterWell expansion, balance sheet improvements, operational transformation, and measured Stars progress — while candidly acknowledging persistent headwinds: medical cost trend outpacing funding, elevated early-year reserves, potential put-option cash exposure, and the need to consider benefit adjustments in 2027. Management emphasized prudence in reserving, disciplined bidding, and multiple levers (operational improvements, M&A, pricing) to meet the 2028 margin objective.View all DE:HUM earnings summariesHUM Revenue Breakdown
94.73% Premiums
4.50% Services
0.78% Investment income
HUM Stock 12 Month Forecast
Average Price Target
€238.84
▲(37.26% Upside)
Technical Analysis
Options Prices
Currently, No data available
---